Market Study: VIVUS, DENTSPLY Intl., Sanofi, and Healthways Inc. Editor Note: For more information about this release, please scroll to bottom PR Newswire LONDON, December 3, 2013 LONDON, December 3, 2013 /PRNewswire/ -- On Monday, December 02, 2013, the S&P 500 Health Care Sector Index ended the day at 638.72, up 0.10%. Shares in the Health Care Sector have gained 3.89% in the last one month and 12.29% in the previous three months, outperforming the S&P 500, which has advanced 2.23% and 10.28% during the respective periods.The U.S. equity market posted losses with the S&P 500 ending the day at1,800.90, down 0.27%; the Dow Jones Industrial Average closing at 16,008.77, down 0.48%; and the NASDAQ Composite finishing at4,045.26, down 0.36%.The major movers in the sector includedVivus Inc. (NASDAQ: VVUS), DENTSPLY International Inc. (NASDAQ: XRAY), Sanofi (NYSE: SNY), and Healthways Inc. (NASDAQ: HWAY). All these companies are tracked by AAAResearchReports.com. Free technical research on VVUS, XRAY, SNY, and HWAY can be downloaded upon signing up at: http://www.aaaresearchreports.com/register/ Vivus I nc.'s stock edged 0.80% higher on Monday, even as the broader market posted losses. The company's shares ended the day at $10.10, after trading between $10.02 and $10.24. A total of 1.11 million shares were traded, which is below the daily average volume of 2.62 million. The company's shares have gained 0.20% in the previous three trading sessions and 5.98% in the last one month, outperforming the S&P 500, which has fallen by 0.10% and has gained 2.23%, during the respective periods. Furthermore, Vivus Inc.'s stock is trading above its 50-day moving average of $9.71. Sign up today to read free research report on VVUS at: http://www.AAAResearchReports.com/VVUS120313.pdf On Monday, shares in DENTSPLY International Inc. fell by 0.38%, tracking losses in the broader market. The company's shares traded between $47.28 and $47.63 before ending the day at $47.38. A total of 0.59 million shares were traded, which is below the daily average volume of 0.77 million. Despite Monday's losses, the company's shares have advanced 0.49% in the last one month and 12.84% in the previous three months, compared to a gain of 2.23% and 10.28% in the S&P 500 during the respective periods. Furthermore, DENTSPLY International Inc.'s stock is trading above its 50-day and 200-day moving averages of $45.85 and $43.02, respectively. Register to download free technical analysis on XRAY at: http://www.AAAResearchReports.com/XRAY120313.pdf Sanofi's stock declined on Monday, to end the day at $52.00, down 1.57% from the previous day's closing price of $52.83. The company's shares vacillated between $51.71 and $52.34 during the trading session. A total of 2.37 million shares were traded, which is above the daily average volume of 1.50 million. Despite Monday's pullback, the company's shares have gained 8.83% in the previous three months, compared to a gain of 10.28% in the S&P 500 during the same period. Moreover, Sanofi's stock is trading above its 50-day and 200-day moving averages of $51.60 and $51.55, respectively. A free report on SNY can be accessed by registering at: http://www.AAAResearchReports.com/SNY120313.pdf On Monday, Healthways Inc.'s stock finished the day at $13.76, which is 1.78% lower than the previous day's closing price of $14.01. The company's shares fluctuated between $13.69 and $14.04 during the trading session. A total of 0.68 million shares were traded, which is below the daily average volume of 0.85 million. Despite Monday's pullback, the company's shares have gained 31.93% in the last one month, outperforming the S&P 500, which has advanced 2.23%, during the same period. Further, Healthways Inc.'s stock is trading below its 50-day and 200-day moving averages of $14.69 and $15.03, respectively. Register with AAA Research Reports and download the research on HWAY for free at: http://www.AAAResearchReports.com/HWAY120313.pdf EDITOR NOTES: 1.This is not company news. We are an independent source and our views do not reflect the companies mentioned. 2.Information in this release is fact checked and produced on a best efforts basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. 3.This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public. 4.If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com. 5.For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com. 6.Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration. COMPLIANCE PROCEDURE Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be. NOT FINANCIAL ADVICE Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein. NO WARRANTY OR LIABILITY ASSUMED Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute. AAAresearchreports.com SOURCE AAA Research Reports Contact: Phone #: + 1 (646) 396-9126 Contact Name: Peter F. Jones Email ID: firstname.lastname@example.org
Market Study: VIVUS, DENTSPLY Intl., Sanofi, and Healthways Inc.
Press spacebar to pause and continue. Press esc to stop.